Search Constraints
« Previous |
41 - 60 of 76
|
Next »
Search Results
Select an image to start the slideshow
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
1 of 20
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
2 of 20
Targeted protein degradation as a new approach to drug discovery
3 of 20
New chemical approaches for the development of targeted protein degradation
4 of 20
The development of chemo- and regioselective reactions of boron systems
5 of 20
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
6 of 20
The design and synthesis of novel epigenetic modulators
7 of 20
The use of contemporary chemoproteomic techniques in antimalarial target identification
8 of 20
Investigations of the synthesis and properties of romodomain and extra-terminal domain proteolysis targeting chimeras
9 of 20
New hydrogen atom transfer methodologies for synthesis
10 of 20
The design, synthesis and optimisation of kinase inhibitors as potential anti-inflammatory agents
11 of 20
The design, synthesis and optimisation of epigenetic mechanism inhibitors
12 of 20
Sustainable cross-couplings for pharmaceutical scale-up using aryldiazonium salts
13 of 20
The development of small molecules for treatment of idiopathic pulmonary fibrosis (IPF)
14 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
15 of 20
Use of fragment-based drug discovery to identify novel drug molecules for challenging biological targets, including protein-protein interactions
16 of 20
Development of chemical probes for non-BET bromodomains
17 of 20
The design and synthesis of chemical probes for non-BET bromodomains
18 of 20
Application of bioisosteres to modulate molecular properties in medicinal chemistry
19 of 20
The application of flow chemistry to the synthesis of pharmaceutically privileged heterocycles
20 of 20